Late initiation of pneumococcal and Haemophilus influenzae type b vaccinations.

IF 3.5
Vaccine Pub Date : 2025-08-30 Epub Date: 2025-08-18 DOI:10.1016/j.vaccine.2025.127611
Alexandria N Albers, Erika R Fox, Sarah Y Michels, Matthew F Daley, Jason M Glanz, Sophia R Newcomer
{"title":"Late initiation of pneumococcal and Haemophilus influenzae type b vaccinations.","authors":"Alexandria N Albers, Erika R Fox, Sarah Y Michels, Matthew F Daley, Jason M Glanz, Sophia R Newcomer","doi":"10.1016/j.vaccine.2025.127611","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>For children who initiate a vaccine series late, the Centers for Disease Control and Prevention (CDC) provides a catch-up schedule to guide providers in achieving full vaccination. Typically, the routine and catch-up schedules recommend the same number of doses for series completion. However, children starting pneumococcal (PCV) or Haemophilus influenzae type b (Hib) vaccination at or after 7 months often require fewer doses than earlier initiators. We aimed to quantify late PCV and Hib series initiators and determine series completion within CDC catch-up guidelines.</p><p><strong>Methods: </strong>This cross-sectional study analyzed vaccine records from the 2016-2021 National Immunization Survey-Child. We quantified the prevalence of and identified characteristics of children who initiated the PCV or Hib series at or after age 7 months (215 days). We evaluated late initiators' series completion based on age of series initiation and when subsequent doses were received.</p><p><strong>Results: </strong>Of 99,652 children, 2.5 % (95 % CI: 2.2-2.7 %) and 2.3 % (95 % CI: 2.1-2.5 %) of U.S. children initiated PCV or Hib series late, respectively. The median age of late series initiation was 384 days for PCV and 407 days for Hib. Overall, 34.9 % (95 % CI: 29.9-39.9 %) of late PCV initiators, and 26.3 % (95 % CI: 21.2-31.4 %) of late Hib initiators, received other vaccines from age 6 weeks to <7 months. Late PCV initiation decreased from 2.9 % (95 % CI: 2.4-3.4 %) in 2016 to 1.7 % (95 % CI: 1.3-2.1 %) in 2021. About 77.4 % (95 % CI: 69.0-83.9 %) of late PCV (routine 4-dose series) and 87.5 % (95 % CI: 76.3-93.3 %) of late Hib (routine 4-dose series) initiators completed the series per catch-up guidelines.</p><p><strong>Conclusions: </strong>A subset of U.S. children initiated the PCV or Hib series at or after 7 months, and most had not received other recommended vaccines between 6 weeks and 7 months-underscoring the need for evidence-based interventions that support early access to primary care.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":"62 ","pages":"127611"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12407149/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.vaccine.2025.127611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/18 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: For children who initiate a vaccine series late, the Centers for Disease Control and Prevention (CDC) provides a catch-up schedule to guide providers in achieving full vaccination. Typically, the routine and catch-up schedules recommend the same number of doses for series completion. However, children starting pneumococcal (PCV) or Haemophilus influenzae type b (Hib) vaccination at or after 7 months often require fewer doses than earlier initiators. We aimed to quantify late PCV and Hib series initiators and determine series completion within CDC catch-up guidelines.

Methods: This cross-sectional study analyzed vaccine records from the 2016-2021 National Immunization Survey-Child. We quantified the prevalence of and identified characteristics of children who initiated the PCV or Hib series at or after age 7 months (215 days). We evaluated late initiators' series completion based on age of series initiation and when subsequent doses were received.

Results: Of 99,652 children, 2.5 % (95 % CI: 2.2-2.7 %) and 2.3 % (95 % CI: 2.1-2.5 %) of U.S. children initiated PCV or Hib series late, respectively. The median age of late series initiation was 384 days for PCV and 407 days for Hib. Overall, 34.9 % (95 % CI: 29.9-39.9 %) of late PCV initiators, and 26.3 % (95 % CI: 21.2-31.4 %) of late Hib initiators, received other vaccines from age 6 weeks to <7 months. Late PCV initiation decreased from 2.9 % (95 % CI: 2.4-3.4 %) in 2016 to 1.7 % (95 % CI: 1.3-2.1 %) in 2021. About 77.4 % (95 % CI: 69.0-83.9 %) of late PCV (routine 4-dose series) and 87.5 % (95 % CI: 76.3-93.3 %) of late Hib (routine 4-dose series) initiators completed the series per catch-up guidelines.

Conclusions: A subset of U.S. children initiated the PCV or Hib series at or after 7 months, and most had not received other recommended vaccines between 6 weeks and 7 months-underscoring the need for evidence-based interventions that support early access to primary care.

肺炎球菌和b型流感嗜血杆菌疫苗接种较晚。
对于接种疫苗较晚的儿童,疾病控制和预防中心(CDC)提供了一份补足时间表,以指导提供者实现全面接种。通常情况下,常规计划和补充计划建议相同剂量的系列完成。然而,在7个月或之后开始接种肺炎球菌(PCV)或b型流感嗜血杆菌(Hib)疫苗的儿童通常需要的剂量比早期接种者少。我们的目的是量化晚期PCV和Hib系列的发起者,并在CDC追赶指南中确定系列的完成情况。方法:本横断面研究分析了2016-2021年全国儿童免疫调查的疫苗记录。我们量化了在7个月(215天)或之后开始感染PCV或Hib系列的儿童的患病率并确定了这些儿童的特征。我们根据起始年龄和接受后续剂量的时间来评估晚起始者的系列完成情况。结果:在99,652名儿童中,2.5% (95% CI: 2.2- 2.7%)和2.3% (95% CI: 2.1- 2.5%)的美国儿童较晚开始PCV或Hib系列。PCV的中位起始年龄为384天,Hib的中位起始年龄为407天。总体而言,34.9% (95% CI: 29.9- 39.9%)的晚期PCV启动者和26.3% (95% CI: 21.2- 31.4%)的晚期Hib启动者在6周龄至7周龄期间接种了其他疫苗。结论:一部分美国儿童在7月龄或7月龄后接种了PCV或Hib系列疫苗,大多数儿童在6周龄至7月龄期间未接种其他推荐疫苗,这强调了支持早期获得初级保健的循证干预措施的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信